Dr Nader P's Best Performance In A Conference Call
Post# of 148337
(Total Views: 494)
Posted On: 03/08/2021 7:56:22 PM
Dr Nader P's Best Performance In A Conference Call
He actually delegated alot. Was very knowledgeable, did superior job answering questions. Did avoid the p value again for overall reduction in deaths, that's OK.
A ton of encouraging stuff. If I was a new investor, I'd come on board.
For those who are already invested, it was a very good cc but unfortunately it was held in the wake of Leronlimab missing the Primary Endpoint, as a result of, as Dr Patteson said today, missing PE due faulty trial design, but that's tough being designed at the beginning of the pandemic.
The conference call went great. They have applied for a conditional EUA while they continue the trial and after seeing the data Philippines has confirmed they are interested in purchasing and we may hear something in as little as 48 hours. Great strides in Nash, Longhaulers already 50% full, great results coming in cancer trials. It’s going to be a phenomenal year for CYDY
Is that correct, did they say they have applied for a "conditional EUA" for critical covid-19???? That could be a big deal if approved. May be an interesting decison for Janet Woodcock, FDA Director.
The near term hope for catalyts are selling to other nations, or the threat of selling to other nations that may prompt Janet to grant a "conditional" or regular EUA. It would seem that either of these can be quickly removed in needed.
He actually delegated alot. Was very knowledgeable, did superior job answering questions. Did avoid the p value again for overall reduction in deaths, that's OK.
A ton of encouraging stuff. If I was a new investor, I'd come on board.
For those who are already invested, it was a very good cc but unfortunately it was held in the wake of Leronlimab missing the Primary Endpoint, as a result of, as Dr Patteson said today, missing PE due faulty trial design, but that's tough being designed at the beginning of the pandemic.
The conference call went great. They have applied for a conditional EUA while they continue the trial and after seeing the data Philippines has confirmed they are interested in purchasing and we may hear something in as little as 48 hours. Great strides in Nash, Longhaulers already 50% full, great results coming in cancer trials. It’s going to be a phenomenal year for CYDY
Is that correct, did they say they have applied for a "conditional EUA" for critical covid-19???? That could be a big deal if approved. May be an interesting decison for Janet Woodcock, FDA Director.
The near term hope for catalyts are selling to other nations, or the threat of selling to other nations that may prompt Janet to grant a "conditional" or regular EUA. It would seem that either of these can be quickly removed in needed.
(7)
(2)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼